{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:28:26Z","timestamp":1793125706072,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,11,21]],"date-time":"2009-11-21T00:00:00Z","timestamp":1258761600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00213-009-1716-z","type":"journal-article","created":{"date-parts":[[2009,11,20]],"date-time":"2009-11-20T22:03:53Z","timestamp":1258754633000},"page":"143-158","source":"Crossref","is-referenced-by-count":73,"title":["Tobacco smoke exposure induces nicotine dependence in rats"],"prefix":"10.1007","volume":"208","author":[{"given":"Elysia","family":"Small","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina P.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake J.","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline E.","family":"Geier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate R.","family":"Yavarovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreedharan N.","family":"Sabarinath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Derendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Pauly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrie W.","family":"Bruijnzeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,21]]},"reference":[{"key":"1716_CR1","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Press, Washington Text revision edition","edition":"4"},{"key":"1716_CR2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neulet.2004.05.020","volume":"366","author":"KL Anderson","year":"2004","unstructured":"Anderson KL, Pinkerton KE, Uyeminami D, Simons CT, Carstens MI, Carstens E (2004) Antinociception induced by chronic exposure of rats to cigarette smoke. Neurosci Lett 366:86\u201391","journal-title":"Neurosci Lett"},{"key":"1716_CR3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1196\/annals.1304.024","volume":"1009","author":"F Aricioglu","year":"2003","unstructured":"Aricioglu F, Altunbas H (2003) Harmane induces anxiolysis and antidepressant-like effects in rats. Ann NY Acad Sci 1009:196\u2013201","journal-title":"Ann NY Acad Sci"},{"key":"1716_CR4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s002130051119","volume":"146","author":"MT Bardo","year":"1999","unstructured":"Bardo MT, Green TA, Crooks PA, Dwoskin LP (1999) Nornicotine is self-administered intravenously by rats. Psychopharmacology (Berl) 146:290\u2013296","journal-title":"Psychopharmacology (Berl)"},{"key":"1716_CR5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.npp.1300586","volume":"30","author":"JD Belluzzi","year":"2005","unstructured":"Belluzzi JD, Wang R, Leslie FM (2005) Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacology 30:705\u2013712","journal-title":"Neuropsychopharmacology"},{"key":"1716_CR6","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJM198811173192005","volume":"319","author":"NL Benowitz","year":"1988","unstructured":"Benowitz NL (1988) Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition. N Engl J Med 319:1318\u20131330","journal-title":"N Engl J Med"},{"key":"1716_CR7","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1471-4159.1988.tb10600.x","volume":"50","author":"ME Benwell","year":"1988","unstructured":"Benwell ME, Balfour DJ, Anderson JM (1988) Evidence that tobacco smoking increases the density of (\u2212)-[3H]nicotine binding sites in human brain. J Neurochem 50:1243\u20131247","journal-title":"J Neurochem"},{"key":"1716_CR8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X","volume":"387","author":"CR Breese","year":"1997","unstructured":"Breese CR, Adams C, Logel J, Drebing C, Rollins Y, Barnhart M, Sullivan B, Demasters BK, Freedman R, Leonard S (1997) Comparison of the regional expression of nicotinic acetylcholine receptor alpha7 mRNA and [125I]-alpha-bungarotoxin binding in human postmortem brain. J Comp Neurol 387:385\u2013398","journal-title":"J Comp Neurol"},{"key":"1716_CR9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0893-133X(00)00121-4","volume":"23","author":"CR Breese","year":"2000","unstructured":"Breese CR, Lee MJ, Adams CE, Sullivan B, Logel J, Gillen KM, Marks MJ, Collins AC, Leonard S (2000) Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology 23:351\u2013364","journal-title":"Neuropsychopharmacology"},{"key":"1716_CR10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00427509","volume":"64","author":"ZW Brown","year":"1979","unstructured":"Brown ZW, Amit Z, Rockman GE (1979) Intraventricular self-administration of acetaldehyde, but not ethanol, in naive laboratory rats. Psychopharmacology (Berl) 64:271\u2013276","journal-title":"Psychopharmacology (Berl)"},{"key":"1716_CR11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/syn.10242","volume":"50","author":"AW Bruijnzeel","year":"2003","unstructured":"Bruijnzeel AW, Markou A (2003) Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats. Synapse 50:20\u201328","journal-title":"Synapse"},{"key":"1716_CR12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.neuropharm.2004.05.005","volume":"47","author":"AW Bruijnzeel","year":"2004","unstructured":"Bruijnzeel AW, Markou A (2004) Adaptations in cholinergic transmission in the ventral tegmental area associated with the affective signs of nicotine withdrawal in rats. Neuropharmacology 47:572\u2013579","journal-title":"Neuropharmacology"},{"key":"1716_CR13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.biopsych.2005.07.020","volume":"59","author":"AW Bruijnzeel","year":"2006","unstructured":"Bruijnzeel AW, Lewis B, Bajpai LK, Morey TE, Dennis DM, Gold M (2006) Severe deficit in brain reward function associated with fentanyl withdrawal in rats. Biol Psychiatry 59:477\u2013480","journal-title":"Biol Psychiatry"},{"key":"1716_CR14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/sj.npp.1301192","volume":"32","author":"AW Bruijnzeel","year":"2007","unstructured":"Bruijnzeel AW, Zislis G, Wilson C, Gold MS (2007) Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats. Neuropsychopharmacology 32:955\u2013963","journal-title":"Neuropsychopharmacology"},{"key":"1716_CR15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00213-008-1321-6","volume":"201","author":"KM Coen","year":"2009","unstructured":"Coen KM, Adamson KL, Corrigall WA (2009) Medication-related pharmacological manipulations of nicotine self-administration in the rat maintained on fixed- and progressive-ratio schedules of reinforcement. Psychopharmacology (Berl) 201:557\u2013568","journal-title":"Psychopharmacology (Berl)"},{"key":"1716_CR16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF00589894","volume":"99","author":"WA Corrigall","year":"1989","unstructured":"Corrigall WA, Coen KM (1989) Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology (Berl) 99:473\u2013478","journal-title":"Psychopharmacology (Berl)"},{"key":"1716_CR17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0006-8993(94)90401-4","volume":"653","author":"WA Corrigall","year":"1994","unstructured":"Corrigall WA, Coen KM, Adamson KL (1994) Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653:278\u2013284","journal-title":"Brain Res"},{"key":"1716_CR18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0006-2952(97)00117-2","volume":"54","author":"PA Crooks","year":"1997","unstructured":"Crooks PA, Dwoskin LP (1997) Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking. Biochem Pharmacol 54:743\u2013753","journal-title":"Biochem Pharmacol"},{"key":"1716_CR19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00213-003-1445-7","volume":"168","author":"JF Cryan","year":"2003","unstructured":"Cryan JF, Bruijnzeel AW, Skjei KL, Markou A (2003) Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology (Berl) 168:347\u2013358","journal-title":"Psychopharmacology (Berl)"},{"key":"1716_CR20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0896-6273(00)80112-9","volume":"16","author":"JA Dani","year":"1996","unstructured":"Dani JA, Heinemann S (1996) Molecular and cellular aspects of nicotine abuse. Neuron 16:905\u2013908","journal-title":"Neuron"},{"key":"1716_CR21","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/jps.10302","volume":"92","author":"D Debruyne","year":"2003","unstructured":"Debruyne D, Sobrio F, Hinschberger A, Camsonne R, Coquerel A, Barre L (2003) Short-term pharmacokinetics and brain distribution of mecamylamine as a preliminary to carbon-11 labeling for nicotinic receptor investigation. J Pharm Sci 92:1051\u20131057","journal-title":"J Pharm Sci"},{"key":"1716_CR22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s002130051153","volume":"147","author":"EC Donny","year":"1999","unstructured":"Donny EC, Caggiula AR, Mielke MM, Booth S, Gharib MA, Hoffman A, Maldovan V, Shupenko C, McCallum SE (1999) Nicotine self-administration in rats on a progressive ratio schedule of reinforcement. Psychopharmacology (Berl) 147:135\u2013142","journal-title":"Psychopharmacology (Berl)"},{"key":"1716_CR23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1503\/cmaj.070256","volume":"179","author":"MJ Eisenberg","year":"2008","unstructured":"Eisenberg MJ, Filion KB, Yavin D, Belisle P, Mottillo S, Joseph L, Gervais A, O'Loughlin J, Paradis G, Rinfret S, Pilote L (2008) Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ 179:135\u2013144","journal-title":"CMAJ"},{"key":"1716_CR24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/30001","volume":"393","author":"MP Epping-Jordan","year":"1998","unstructured":"Epping-Jordan MP, Watkins SS, Koob GF, Markou A (1998) Dramatic decreases in brain reward function during nicotine withdrawal. Nature 393:76\u201379","journal-title":"Nature"},{"key":"1716_CR25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.euroneuro.2005.08.005","volume":"16","author":"D Farzin","year":"2006","unstructured":"Farzin D, Mansouri N (2006) Antidepressant-like effect of harmane and other beta-carbolines in the mouse forced swim test. Eur Neuropsychopharmacol 16:324\u2013328","journal-title":"Eur Neuropsychopharmacol"},{"key":"1716_CR26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0376-8716(96)01327-0","volume":"44","author":"J Foulds","year":"1997","unstructured":"Foulds J, Stapleton JA, Bell N, Swettenham J, Jarvis MJ, Russell MA (1997) Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers. Drug Alcohol Depend 44:105\u2013115","journal-title":"Drug Alcohol Depend"},{"key":"1716_CR27","doi-asserted-by":"crossref","first-page":"14065","DOI":"10.1073\/pnas.93.24.14065","volume":"93","author":"JS Fowler","year":"1996","unstructured":"Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, Alexoff D, MacGregor RR, Schlyer DJ, Zezulkova I, Wolf AP (1996) Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci USA 93:14065\u201314069","journal-title":"Proc Natl Acad Sci USA"},{"key":"1716_CR28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1300\/J069v17n01_03","volume":"17","author":"JS Fowler","year":"1998","unstructured":"Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Wolf AP, Warner D, Cilento R, Zezulkova I (1998) Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition. J Addict Dis 17:23\u201334","journal-title":"J Addict Dis"},{"key":"1716_CR29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0161-813X(02)00109-2","volume":"24","author":"JS Fowler","year":"2003","unstructured":"Fowler JS, Logan J, Wang GJ, Volkow ND (2003) Monoamine oxidase and cigarette smoking. Neurotoxicology 24:75\u201382","journal-title":"Neurotoxicology"},{"key":"1716_CR30","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0090-9556(24)14955-0","volume":"27","author":"O Ghosheh","year":"1999","unstructured":"Ghosheh O, Dwoskin LP, Li WK, Crooks PA (1999) Residence times and half-lives of nicotine metabolites in rat brain after acute peripheral administration of [2'-(14)C]nicotine. Drug Metab Dispos 27:1448\u20131455","journal-title":"Drug Metab Dispos"},{"key":"1716_CR31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1360-0443.1985.tb03008.x","volume":"80","author":"NE Grunberg","year":"1985","unstructured":"Grunberg NE (1985) Nicotine, cigarette smoking, and body weight. Br J Addict 80:369\u2013377","journal-title":"Br J Addict"},{"key":"1716_CR32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00427430","volume":"83","author":"NE Grunberg","year":"1984","unstructured":"Grunberg NE, Bowen DJ, Morse DE (1984) Effects of nicotine on body weight and food consumption in rats. Psychopharmacology (Berl) 83:93\u201398","journal-title":"Psychopharmacology (Berl)"},{"key":"1716_CR33","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s002130050831","volume":"141","author":"AA Harrison","year":"1999","unstructured":"Harrison AA, Parsons LH, Koob GF, Markou A (1999) RU 24969, a 5-HT1A\/1B agonist, elevates brain stimulation reward thresholds: an effect reversed by GR 127935, a 5-HT1B\/1D antagonist. Psychopharmacology (Berl) 141:242\u2013250","journal-title":"Psychopharmacology (Berl)"},{"key":"1716_CR34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0893-133X(00)00237-2","volume":"25","author":"AA Harrison","year":"2001","unstructured":"Harrison AA, Liem YT, Markou A (2001) Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats. Neuropsychopharmacology 25:55\u201371","journal-title":"Neuropsychopharmacology"},{"key":"1716_CR35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00213-001-0953-6","volume":"160","author":"AA Harrison","year":"2002","unstructured":"Harrison AA, Gasparini F, Markou A (2002) Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats. Psychopharmacology (Berl) 160:56\u201366","journal-title":"Psychopharmacology (Berl)"},{"key":"1716_CR36","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbrc.2004.11.033","volume":"326","author":"T Herraiz","year":"2005","unstructured":"Herraiz T, Chaparro C (2005) Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors. Biochem Biophys Res Commun 326:378\u2013386","journal-title":"Biochem Biophys Res Commun"},{"key":"1716_CR37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0026-895X(25)10246-0","volume":"48","author":"RA Houghtling","year":"1995","unstructured":"Houghtling RA, Davila-Garcia MI, Kellar KJ (1995) Characterization of (+\/\u2212)(\u2212)[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol Pharmacol 48:280\u2013287","journal-title":"Mol Pharmacol"},{"key":"1716_CR38","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0022-3565(24)37134-4","volume":"283","author":"WR Kem","year":"1997","unstructured":"Kem WR, Mahnir VM, Papke RL, Lingle CJ (1997) Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors. J Pharmacol Exp Ther 283:979\u2013992","journal-title":"J Pharmacol Exp Ther"},{"key":"1716_CR39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1196\/annals.1300.040","volume":"1003","author":"PJ Kenny","year":"2003","unstructured":"Kenny PJ, Paterson NE, Boutrel B, Semenova S, Harrison AA, Gasparini F, Koob GF, Skoubis PD, Markou A (2003) Metabotropic glutamate 5 receptor antagonist MPEP decreased nicotine and cocaine self-administration but not nicotine and cocaine-induced facilitation of brain reward function in rats. Ann NY Acad Sci 1003:415\u2013418","journal-title":"Ann NY Acad Sci"},{"key":"1716_CR40","first-page":"2473","volume":"38","author":"C Kornetsky","year":"1979","unstructured":"Kornetsky C, Esposito RU (1979) Euphorigenic drugs: effects on the reward pathways of the brain. Fed Proc 38:2473\u20132476","journal-title":"Fed Proc"},{"key":"1716_CR41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0090-9556(25)06886-2","volume":"16","author":"GA Kyerematen","year":"1988","unstructured":"Kyerematen GA, Taylor LH, deBethizy JD, Vesell ES (1988) Pharmacokinetics of nicotine and 12 metabolites in the rat. Application of a new radiometric high performance liquid chromatography assay. Drug Metab Dispos 16:125\u2013129","journal-title":"Drug Metab Dispos"},{"key":"1716_CR42","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/j.1552-4604.1998.tb05787.x","volume":"38","author":"GM Lawson","year":"1998","unstructured":"Lawson GM, Hurt RD, Dale LC, Offord KP, Croghan IT, Schroeder DR, Jiang NS (1998) Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. J Clin Pharmacol 38:502\u2013509","journal-title":"J Clin Pharmacol"},{"key":"1716_CR43","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jpba.2007.11.024","volume":"48","author":"A Maciuk","year":"2008","unstructured":"Maciuk A, Moaddel R, Haginaka J, Wainer IW (2008) Screening of tobacco smoke condensate for nicotinic acetylcholine receptor ligands using cellular membrane affinity chromatography columns and missing peak chromatography. J Pharm Biomed Anal 48:238\u2013246","journal-title":"J Pharm Biomed Anal"},{"key":"1716_CR44","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0091-3057(92)90408-8","volume":"43","author":"DH Malin","year":"1992","unstructured":"Malin DH, Lake JR, Newlin-Maultsby P, Roberts LK, Lanier JG, Carter VA, Cunningham JS, Wilson OB (1992) Rodent model of nicotine abstinence syndrome. Pharmacol Biochem Behav 43:779\u2013784","journal-title":"Pharmacol Biochem Behav"},{"key":"1716_CR45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0031-9384(92)90211-J","volume":"51","author":"A Markou","year":"1992","unstructured":"Markou A, Koob GF (1992) Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiol Behav 51:111\u2013119","journal-title":"Physiol Behav"},{"key":"1716_CR46","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0022-3565(25)21831-6","volume":"226","author":"MJ Marks","year":"1983","unstructured":"Marks MJ, Burch JB, Collins AC (1983) Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Ther 226:817\u2013825","journal-title":"J Pharmacol Exp Ther"},{"key":"1716_CR47","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.ph.57.030195.002513","volume":"57","author":"DS McGehee","year":"1995","unstructured":"McGehee DS, Role LW (1995) Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57:521\u2013546","journal-title":"Annu Rev Physiol"},{"key":"1716_CR48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bcp.2007.06.010","volume":"75","author":"YS Mineur","year":"2008","unstructured":"Mineur YS, Picciotto MR (2008) Genetics of nicotinic acetylcholine receptors: relevance to nicotine addiction. Biochem Pharmacol 75:323\u2013333","journal-title":"Biochem Pharmacol"},{"key":"1716_CR49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0014-2999(98)00084-3","volume":"347","author":"EJ Molinari","year":"1998","unstructured":"Molinari EJ, Delbono O, Messi ML, Renganathan M, Arneric SP, Sullivan JP, Gopalakrishnan M (1998) Up-regulation of human alpha7 nicotinic receptors by chronic treatment with activator and antagonist ligands. Eur J Pharmacol 347:131\u2013139","journal-title":"Eur J Pharmacol"},{"key":"1716_CR50","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0091-3057(82)90364-1","volume":"17","author":"WD Myers","year":"1982","unstructured":"Myers WD, Ng KT, Singer G (1982) Intravenous self-administration of acetaldehyde in the rat as a function of schedule, food deprivation and photoperiod. Pharmacol Biochem Behav 17:807\u2013811","journal-title":"Pharmacol Biochem Behav"},{"key":"1716_CR51","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1124\/jpet.103.056408","volume":"307","author":"HN Nguyen","year":"2003","unstructured":"Nguyen HN, Rasmussen BA, Perry DC (2003) Subtype-selective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography. J Pharmacol Exp Ther 307:1090\u20131097","journal-title":"J Pharmacol Exp Ther"},{"key":"1716_CR52","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00213-006-0383-6","volume":"186","author":"LE O'Dell","year":"2006","unstructured":"O'Dell LE, Bruijnzeel AW, Smith RT, Parsons LH, Merves ML, Goldberger BA, Richardson HN, Koob GF, Markou A (2006) Diminished nicotine withdrawal in adolescent rats: implications for vulnerability to addiction. Psychopharmacology (Berl) 186:612\u2013619","journal-title":"Psychopharmacology (Berl)"},{"key":"1716_CR53","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.addbeh.2006.12.024","volume":"32","author":"CT Okoli","year":"2007","unstructured":"Okoli CT, Kelly T, Hahn EJ (2007) Secondhand smoke and nicotine exposure: a brief review. Addict Behav 32:1977\u20131988","journal-title":"Addict Behav"},{"key":"1716_CR54","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s002130000559","volume":"152","author":"NE Paterson","year":"2000","unstructured":"Paterson NE, Myers C, Markou A (2000) Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats. Psychopharmacology (Berl) 152:440\u2013446","journal-title":"Psychopharmacology (Berl)"},{"key":"1716_CR55","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0022-3565(25)20464-5","volume":"258","author":"JR Pauly","year":"1991","unstructured":"Pauly JR, Marks MJ, Gross SD, Collins AC (1991) An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. J Pharmacol Exp Ther 258:1127\u20131136","journal-title":"J Pharmacol Exp Ther"},{"key":"1716_CR56","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0091-3057(96)00216-X","volume":"56","author":"KA Perkins","year":"1997","unstructured":"Perkins KA, Grobe JE, Caggiula A, Wilson AS, Stiller RL (1997) Acute reinforcing effects of low-dose nicotine nasal spray in humans. Pharmacol Biochem Behav 56:235\u2013241","journal-title":"Pharmacol Biochem Behav"},{"key":"1716_CR57","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0022-3565(25)12091-0","volume":"275","author":"DC Perry","year":"1995","unstructured":"Perry DC, Kellar KJ (1995) [3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study. J Pharmacol Exp Ther 275:1030\u20131034","journal-title":"J Pharmacol Exp Ther"},{"key":"1716_CR58","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0022-3565(24)38304-1","volume":"289","author":"DC Perry","year":"1999","unstructured":"Perry DC, Davila-Garcia MI, Stockmeier CA, Kellar KJ (1999) Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J Pharmacol Exp Ther 289:1545\u20131552","journal-title":"J Pharmacol Exp Ther"},{"key":"1716_CR59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neulet.2006.05.010","volume":"404","author":"BA Rasmussen","year":"2006","unstructured":"Rasmussen BA, Perry DC (2006) An autoradiographic analysis of [125I]alpha-bungarotoxin binding in rat brain after chronic nicotine exposure. Neurosci Lett 404:9\u201314","journal-title":"Neurosci Lett"},{"key":"1716_CR60","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.npep.2008.03.004","volume":"42","author":"D Rylkova","year":"2008","unstructured":"Rylkova D, Boissoneault J, Isaac S, Prado M, Shah HP, Bruijnzeel AW (2008) Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats. Neuropeptides 42:215\u2013227","journal-title":"Neuropeptides"},{"key":"1716_CR61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0014-2999(76)90201-6","volume":"38","author":"MD Schechter","year":"1976","unstructured":"Schechter MD, Cook PG (1976) Nicotine-induced weight loss in rats without an effect on appetite. Eur J Pharmacol 38:63\u201369","journal-title":"Eur J Pharmacol"},{"key":"1716_CR62","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1073\/pnas.92.13.5880","volume":"92","author":"G Schulteis","year":"1995","unstructured":"Schulteis G, Markou A, Cole M, Koob GF (1995) Decreased brain reward produced by ethanol withdrawal. Proc Natl Acad Sci USA 92:5880\u20135884","journal-title":"Proc Natl Acad Sci USA"},{"key":"1716_CR63","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/ajcn\/55.4.878","volume":"55","author":"SR Schwid","year":"1992","unstructured":"Schwid SR, Hirvonen MD, Keesey RE (1992) Nicotine effects on body weight: a regulatory perspective. Am J Clin Nutr 55:878\u2013884","journal-title":"Am J Clin Nutr"},{"key":"1716_CR64","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0741-8329(84)90097-1","volume":"1","author":"BR Smith","year":"1984","unstructured":"Smith BR, Amit Z, Splawinsky J (1984) Conditioned place preference induced by intraventricular infusions of acetaldehyde. Alcohol 1:193\u2013195","journal-title":"Alcohol"},{"key":"1716_CR65","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1073\/pnas.0409591102","volume":"102","author":"KR Smith","year":"2005","unstructured":"Smith KR, Pinkerton KE, Watanabe T, Pedersen TL, Ma SJ, Hammock BD (2005) Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor. Proc Natl Acad Sci USA 102:2186\u20132191","journal-title":"Proc Natl Acad Sci USA"},{"key":"1716_CR66","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s002130050818","volume":"141","author":"JA Sparks","year":"1999","unstructured":"Sparks JA, Pauly JR (1999) Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57Bl\/6 mice. Psychopharmacology (Berl) 141:145\u2013153","journal-title":"Psychopharmacology (Berl)"},{"key":"1716_CR67","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF02245088","volume":"117","author":"IP Stolerman","year":"1995","unstructured":"Stolerman IP, Jarvis MJ (1995) The scientific case that nicotine is addictive. Psychopharmacology (Berl) 117:2\u201310","journal-title":"Psychopharmacology (Berl)"},{"key":"1716_CR68","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.euroneuro.2007.02.013","volume":"17","author":"R Talhout","year":"2007","unstructured":"Talhout R, Opperhuizen A, van Amsterdam JG (2007) Role of acetaldehyde in tobacco smoke addiction. Eur Neuropsychopharmacol 17:627\u2013636","journal-title":"Eur Neuropsychopharmacol"},{"key":"1716_CR69","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/08958379409029697","volume":"6","author":"SV Teague","year":"1994","unstructured":"Teague SV, Pinkerton KE, Goldsmith M, Gebremichael A, Chang S, Jenkins RA, Moneyhun JH (1994) A sidestream cigarette smoke generation and exposure system for environmental tobacco smoke studies. Inhalation Toxicology 6:79\u201393","journal-title":"Inhalation Toxicology"},{"key":"1716_CR70","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3835(99)00143-3","volume":"143","author":"Y Totsuka","year":"1999","unstructured":"Totsuka Y, Ushiyama H, Ishihara J, Sinha R, Goto S, Sugimura T, Wakabayashi K (1999) Quantification of the co-mutagenic beta-carbolines, norharman and harman, in cigarette smoke condensates and cooked foods. Cancer Lett 143:139\u2013143","journal-title":"Cancer Lett"},{"key":"1716_CR71","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0006-8993(00)02208-3","volume":"867","author":"JA Trauth","year":"2000","unstructured":"Trauth JA, Seidler FJ, Slotkin TA (2000) An animal model of adolescent nicotine exposure: effects on gene expression and macromolecular constituents in rat brain regions. Brain Res 867:29\u201339","journal-title":"Brain Res"},{"key":"1716_CR72","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2105\/AJPH.78.6.699","volume":"78","author":"MA Wall","year":"1988","unstructured":"Wall MA, Johnson J, Jacob P, Benowitz NL (1988) Cotinine in the serum, saliva, and urine of nonsmokers, passive smokers, and active smokers. Am J Public Health 78:699\u2013701","journal-title":"Am J Public Health"},{"key":"1716_CR73","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s002130050041","volume":"148","author":"A Wall","year":"2000","unstructured":"Wall A, Gong ZH, Johnson AE, Meyerson B, Zhang X (2000) Cross-tolerance in drug response and differential changes in central nicotinic and N-methyl-D-aspartate receptor binding following chronic treatment with either (+)- or (\u2212)-nicotine. Psychopharmacology (Berl) 148:186\u2013195","journal-title":"Psychopharmacology (Berl)"},{"key":"1716_CR74","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0091-3057(98)00226-3","volume":"62","author":"SS Watkins","year":"1999","unstructured":"Watkins SS, Epping-Jordan MP, Koob GF, Markou A (1999) Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacol Biochem Behav 62:743\u2013751","journal-title":"Pharmacol Biochem Behav"},{"key":"1716_CR75","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF02245178","volume":"117","author":"RA Wise","year":"1995","unstructured":"Wise RA, Munn E (1995) Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds. Psychopharmacology (Berl) 117:130\u2013136","journal-title":"Psychopharmacology (Berl)"},{"key":"1716_CR76","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/0006-2952(95)02100-0","volume":"50","author":"SL Yates","year":"1995","unstructured":"Yates SL, Bencherif M, Fluhler EN, Lippiello PM (1995) Up-regulation of nicotinic acetylcholine receptors following chronic exposure of rats to mainstream cigarette smoke or alpha 4 beta 2 receptors to nicotine. Biochem Pharmacol 50:2001\u20132008","journal-title":"Biochem Pharmacol"},{"key":"1716_CR77","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0006-8993(94)90343-3","volume":"644","author":"X Zhang","year":"1994","unstructured":"Zhang X, Gong ZH, Nordberg A (1994) Effects of chronic treatment with (+)- and (\u2212)-nicotine on nicotinic acetylcholine receptors and N-methyl-D-aspartate receptors in rat brain. Brain Res 644:32\u201339","journal-title":"Brain Res"},{"key":"1716_CR78","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s007020200030","volume":"109","author":"X Zhang","year":"2002","unstructured":"Zhang X, Tian JY, Svensson AL, Gong ZH, Meyerson B, Nordberg A (2002) Chronic treatments with tacrine and (\u2212)-nicotine induce different changes of nicotinic and muscarinic acetylcholine receptors in the brain of aged rat. J Neural Transm 109:377\u2013392","journal-title":"J Neural Transm"},{"key":"1716_CR79","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/carcin\/bgi189","volume":"26","author":"CY Zhong","year":"2005","unstructured":"Zhong CY, Zhou YM, Douglas GC, Witschi H, Pinkerton KE (2005) MAPK\/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats. Carcinogenesis 26:2187\u20132195","journal-title":"Carcinogenesis"},{"key":"1716_CR80","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.neuropharm.2007.09.007","volume":"58","author":"G Zislis","year":"2007","unstructured":"Zislis G, Desai TV, Prado M, Shah HP, Bruijnzeel AW (2007) Effects of the CRF receptor antagonist D-Phe CRF(12\u201341) and the alpha2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats. Neuropharmacology 58:958\u2013966","journal-title":"Neuropharmacology"},{"key":"1716_CR81","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1523\/JNEUROSCI.18-12-04461.1998","volume":"18","author":"M Zoli","year":"1998","unstructured":"Zoli M, Lena C, Picciotto MR, Changeux JP (1998) Identification of four classes of brain nicotinic receptors using beta2 mutant mice. J Neurosci 18:4461\u20134472","journal-title":"J Neurosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-009-1716-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-009-1716-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-009-1716-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T05:29:08Z","timestamp":1739424548000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-009-1716-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,21]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["1716"],"URL":"https:\/\/doi.org\/10.1007\/s00213-009-1716-z","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1553956.1044054","asserted-by":"object"}]},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,21]]}}}